Alpha Innotech Corp (APNO)

[beigledog]

Here's the PR on the new CFO...

Alpha Innotech Appoints Michael Henighan Chief Financial Officer
Thursday August 21, 10:34 am ET


SAN LEANDRO, Calif.--(BUSINESS WIRE)--Alpha Innotech Corp. (OTCBB:APNO - News), a leading provider of bioanalytical systems for drug discovery and life science research, announced that Michael Henighan has been appointed Chief Financial Officer and Principal Accounting Officer effective immediately.

Mr. Henighan brings valuable experience from his work at other publicly-traded biotechnology companies. Prior to joining the Company as Corporate Controller in May of 2008, Mr. Henighan was Vice President and Corporate Controller at HemoSense, Inc. (AMEX:HEM - News) and Corporate Controller at Cholestech Corp. (Nasdaq:CTEC - News). He also held senior management positions with Applied Biosystems, Solectron and Motorola.

“I am honored to be offered this leadership role at Alpha Innotech. I’m looking forward to working with the many talented professionals in our Company to increase our profitability and add to our shareholders’ value,” said Mr. Henighan.

“In the few short months Michael has been with us he’s already been a great asset as we continue building profitable growth momentum,” said Ron Bissinger, Alpha Innotech’s CEO. “We’re delighted to appoint Michael as our top financial executive.”